Figure 2 | Scientific Reports

Figure 2

From: Efficacy and Safety of Panobinostat in Relapsed or/and Refractory Multiple Myeloma: Meta Analyses of Clinical Trials and Systematic Review

Figure 2

Forest plots for meta analysis of ORR.

(A) ORR for panobinostat combined with any other drugs (B). Subanalysis of ORR for panobinostat combined with proteasome inhibitors with or without dexamethasone. ORR, overall response rate; CI, confidence interval; I-squared values indicate significant heterogeneity between individual studies.

Back to article page